Top analysts on stock perps · Analyst
James Quigley (Goldman Sachs): analyst track record on stock perps
James Quigley of Goldman Sachs on companies with stock perpetual futures: star rating, success rate, price-target accuracy, current calls and the measured perp reaction after each rating.
Stars0.2★
Success39%
Excess return-7.0%
rank#11,965
Ratings175
ratings on stock perps14
Track record
TipRanks data via FMP| 12 months | 3 years | |
|---|---|---|
| Ratings | 53 | 121 |
| Stock | 19 | 24 |
| Buy / hold / sell | 27 / 23 / 3 | 43 / 53 / 25 |
| Upgrades / downgrades / initiations | 3 / 2 / 0 | 6 / 4 / 5 |
| Price targets hit / missed | 15 / 37 (29%) | 58 / 60 (49%) |
| Avg. return after a rating (TipRanks) | -5.8% | +9.6% |
| Best / worst call | +43.3% / -42.9% | +83.1% / -75.7% |
After buy calls: not enough measured cases yet
Current calls on stock perps
| Stock | Call | Target | vs last close | Date |
|---|---|---|---|---|
| $NVO Novo Nordisk A/S | Hold · Maintained | $44.00 | +12.7% | Aug 6, 2026 |
Recent ratings
- Aug 6, 2026 $NVO: Maintained · Hold · $44.00 · article
- Jun 3, 2026 $NVO: Maintained · Hold · $47.00 · article
- Mar 3, 2026 $NVO: Downgraded · Hold · $41.00 · article
- Jan 23, 2026 $NVO: Maintained · Buy · $68.00 · article
- Nov 28, 2025 $NVO: Maintained · Buy · $54.00 · article
- Sep 12, 2025 $NVS: Downgraded · Sell · $118 · article
- Jan 13, 2025 $NVO: Maintained · Buy · $124 · article
- Aug 8, 2024 $NVO: Maintained · Buy · article
- Sep 5, 2024 $NVS: Downgraded · Hold · $121 · article
- Jun 26, 2024 $NVO: Maintained · Buy · $153 · article
- Jul 19, 2024 $NVO: Maintained · Buy · $160 · article
- May 30, 2024 $AZN: Initiated · Buy · $204 · article
- May 30, 2024 $NVS: Initiated · Buy · $120 · article
- May 30, 2024 $NVO: Initiated · Buy · $156 · article
James Quigley0.2★ · 39% success · -7.0% excess return · TipRanks data via FMP · Source headlines via TheFly/StreetInsider (FMP). Reaction = venue-median perp move after our detection — an observation, not investment advice.